Application number  =>  596/MUMNP/2012 A 

Date of filing of application number  =>  12/03/2012 

Publication date  =>  31/08/2012 

Title  =>  HBV ANTISENSE INHIBITORS 

Name of applicant  =>  1)GLAXO GROUP LIMITED 

Name of inventor  =>  1)HAMATAKE , ROBERT 

International Classification  =>  A61K 31/7115 

Priority Doc No  =>  61/252,380 

International Application Number  =>  PCT/US2010/052911 

International Publication Number  =>  WO/2011/047312 

Abstract  =>  Antisense oligomers useful for modulating hepatitis B virus infections, and for the treatment of hepatitis B virus (HBV) and hepatitis B virus-related conditions in animals including humans. More particularly, antisense oligomers with modified nucleotides for treatment of HBV in animals, more particularly antisense oligomers comprising 2O-4C- methylene-bridged sugars, or nucleotides with other 2O-4C bridged sugars, also known as locked nucleic acids (LNA), for treatment of HBV in animals, and more particularly for treatment of HBV in humans. 

